Moses Lake Pharmacy Recalls Compounded Testosterone Cypionate Injectable Solution
Moses Lake Professional Pharmacy is recalling compounded Testosterone Cypionate injectable solution due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects are rated Severe (4). While no injuries are reported, the lack of sterility assurance in an injectable drug represents a significant risk of serious harm (sepsis, infection), fitting the 'Severe' criteria for high-risk products where injury has not yet been reported but the potential for serious harm is high.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling specific lots of compounded Testosterone Cypionate Injectable Solution, 200 MG/ML. The affected product is available in 5mL and 10mL syringes and is prescription-only. The recall involves 38 10mL syringes and 7 5mL syringes.
The recall was initiated because of a lack of assurance of sterility for all sterile human compounded drugs within their expiry dates. The source text does not specify the exact nature of the sterility failure or the specific pathogens involved.
The affected product was distributed nationwide. Consumers who have this product should contact their healthcare provider or the pharmacy for instructions on how to proceed. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- TESTOSTERONE CYPIONATE (COMPOUNDED), Injectable Solution, 200 MG/ML, syringe sizes: 5mL and 10mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- t12232014@27
- t11112014@12
- t08072014@38
- t07142015@22
- t07102015@26
- t06232014@25
- t06042015@24
- 06172015@13
- 04202015@7
- 03092015@11
- 02022015@3
- 01192015@8
- 01052015@10.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharm D Solutions Recalls Testosterone Cypionate/Proprinate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereTestosterone Cypionate Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- SevereKey Pharmacy Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereJohn W Hollis Inc Recalls Testosterone Cypionate Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereTestosterone Cypionate Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Cypionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23